Physician profile
Su H Wang
NPI 1972639755
$12,597.50
in general payments reported to CMS, 2019-2025
18 companies · $584 in 2025
The $584 reported for 2025 was more than what 76% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,310 · 2020: $22.91 · 2021: $2,376 · 2022: $104 · 2023: $2,858 · 2024: $343 · 2025: $584.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,914 · Travel and Lodging: $1,871.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,914.14 |
| Travel and Lodging | $1,870.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $11,291.55 | 2019-2025 | |
| Pfizer INC. | $251.32 | 2021-2025 | |
| Glaxosmithkline, LLC. | $229.43 | 2022-2025 | Arexvy, Shingrix |
| Novo Nordisk INC | $145.27 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Dynavax Technologies Corporation | $144.50 | 2019-2025 | Heplisav-B |
| Abbott Laboratories | $109.13 | 2023-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $87.57 | 2024-2025 | Jardiance, Tradjenta, Synjardy |
| Dexcom, INC. | $56.63 | 2023 | Dexcom G6 Transmitter |
| Abbvie INC. | $43.71 | 2021-2025 | |
| Amarin Pharma, INC. | $41.04 | 2019-2021 | |
| Ibsa Pharma INC. | $32.84 | 2024 | Tirosint, Licart, Flector |
| Janssen Pharmaceuticals, INC | $32.61 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $29.12 | 2022-2024 | Breztri |
| Merck Sharp & Dohme LLC | $29.05 | 2023 | Gardasil 9 |
| Boston Scientific Corporation | $27.87 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vbi Vaccine (Delaware) INC. | $16.41 | 2023 | Prehevbrio |
| Hologic Sales and Service, LLC | $15.95 | 2025 | Aptima |
| Kowa Pharmaceuticals America, INC. | $13.50 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Su Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.